AAAAAA

   
Results: 1-8 |
Results: 8
Difference in patient's acceptance of early versus late initiation of psychosocial support in breast cancer
Authors: Scholten, C Weinlander, G Krainer, M Frischenschlager, O Zielinski, CC
Citation: C. Scholten et al., Difference in patient's acceptance of early versus late initiation of psychosocial support in breast cancer, SUPP CARE C, 9(6), 2001, pp. 459-464
Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: Results of a phase II trial
Authors: Kostler, WJ Brodowicz, T Attems, Y Hejna, M Tomek, S Amann, G Fiebiger, WCC Wiltschke, C Krainer, M Zielinski, CC
Citation: Wj. Kostler et al., Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: Results of a phase II trial, ANN ONCOL, 12(9), 2001, pp. 1281-1288
Soluble ICAM-1 in breast cancer: clinical significance and biological implications
Authors: Kostler, WJ Tomek, S Brodowicz, T Budinsky, AC Flamm, M Hejna, M Krainer, M Wiltschke, C Zielinski, CC
Citation: Wj. Kostler et al., Soluble ICAM-1 in breast cancer: clinical significance and biological implications, CANCER IMMU, 50(9), 2001, pp. 483-490
High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinoma
Authors: Pribill, I Speiser, P Leary, J Leodolter, S Hacker, NF Friedlander, ML Birnbaum, D Zeillinger, R Krainer, M
Citation: I. Pribill et al., High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinoma, CANC GENET, 129(1), 2001, pp. 23-29
Transient increase in mitogen-induced lymphoproliferative responses in patients with testicular cancer after BEP chemotherapy
Authors: Krainer, M Wolf, HM Wiltschke, C Wilfing, B Kaider, A Kratzik, C Eibl, MM Zielinski, CC
Citation: M. Krainer et al., Transient increase in mitogen-induced lymphoproliferative responses in patients with testicular cancer after BEP chemotherapy, UROLOGY, 55(6), 2000, pp. 934-938
Induction of immunomediated diseases by recombinant human granulocyte-macrophage colony-stimulating factor during cancer treatment?
Authors: Locker, GJ Steger, GG Gnant, MFX Steiner, B Simonitsch, I Krainer, M Budinsky, A Brodowicz, T Spitzauer, S Jakesz, R Zielinski, CC
Citation: Gj. Locker et al., Induction of immunomediated diseases by recombinant human granulocyte-macrophage colony-stimulating factor during cancer treatment?, J IMMUNOTH, 22(1), 1999, pp. 85-89
Common nonsense mutations in RAD52
Authors: Bell, DW Wahrer, DCR Kang, DH MacMahon, MS FitzGerald, MG Ishioka, C Isselbacher, KJ Krainer, M Haber, DA
Citation: Dw. Bell et al., Common nonsense mutations in RAD52, CANCER RES, 59(16), 1999, pp. 3883-3888
Influence of etoposide on the retention of radiolabeled low-density lipoprotein in the arterial wall
Authors: Krainer, M Rodrigues, M Zielinski, C Sinzinger, H
Citation: M. Krainer et al., Influence of etoposide on the retention of radiolabeled low-density lipoprotein in the arterial wall, ARCH PATH L, 123(6), 1999, pp. 514-518
Risultati: 1-8 |